22 New 4-Star Stocks This Week
Morningstar identified 22 newly undervalued stocks, including Amazon (AMZN), UnitedHealth Group (UNH), Texas Instruments (TXN), Arista Networks (ANET), and Analog Devices (ADI). These stocks now have a 4-star rating, trading below their fair value estimates. The US stock market is moderately undervalued, with 34% of covered stocks undervalued.
How this was made
The 30-second read
Why it matters
The rating changes provide fresh valuation signals but lack a material catalyst, limiting immediate trading impact.
Market read
The article offers new valuation data for five large U.S. companies, useful for value‑oriented strategies.
What to watch
No fundamental change; price declines may reflect sector‑wide pressures.
Background
Morningstar weekly screen identifies newly undervalued U.S. stocks and updates their star ratings.
Ticker impact
Amazon received a Morningstar 4‑star rating after its price fell 1.53% and is now 14% below fair value.
Potential modest upside as value funds add position.
Morningstar rating change is a new data point but limited to valuation view.
UnitedHealth Group was upgraded to a 4‑star rating after a 2.89% weekly decline, now trading 18% below fair value.
Likely limited upside, mainly from value‑seeking investors.
Rating change is fresh but modest in scale.
Texas Instruments dropped 5.44% and moved to a 4‑star Morningstar rating, now 19% under fair value.
Small upside potential if price corrects toward fair value.
Rating shift is new information but impact limited to valuation perception.
Arista Networks received a 4‑star rating after a 5.12% loss, trading 18% below fair value.
Modest upside if market re‑prices the discount.
Rating update is a fresh data point but not a catalyst for large moves.
Analog Devices was upgraded to a 4‑star rating after a 4.19% decline, now 16% below its new fair‑value estimate.
Potential modest rally toward fair value.
New rating provides fresh valuation insight, limited in scale.
Market effects
Highlights undervaluation across tech and healthcare sectors.
U.S. market may see modest value‑flow into listed stocks.
Limited to investors tracking Morningstar ratings.
Counterpoint
Rating upgrades may be premature if broader market sentiment remains bearish.
Key entities
- Research FirmMorningstar
Provider of the star rating methodology.
